aluates Reports

$ 0.0

Automative

Global Congestive Heart Failure (CHF) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-4P3167

Global Congestive Heart Failure CHF Market Insights and Forecast to 2028

BUY CHAPTERS

Global Congestive Heart Failure (CHF) Market Research Report 2025

Code: QYRE-Auto-4P3167

Report

September 2025

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Novartis

Pfizer Inc

Merck

Astrazeneca plc

GSK

Bristol–Myers Squibb

Mylan NV

Bausch Health

Johnson & Johnson

Bayer

Boehringer Inhelheim

Exelixis Inc

Lunan Pharmaceutical

Sinepharm

CRC

Hai Ni Pharmaceutical

Langtian

NCPC

Hayao

Xinhua Group

Xudong Haipu Pharmaceutical

Congestive Heart Failure (CHF) Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Congestive Heart Failure (CHF) Market

The global market for Congestive Heart Failure (CHF) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Congestive Heart Failure (CHF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congestive Heart Failure (CHF).

The Congestive Heart Failure (CHF) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Congestive Heart Failure (CHF) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Congestive Heart Failure (CHF) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Congestive Heart Failure (CHF) Market Report

Report Metric	Details
Report Name	Congestive Heart Failure (CHF) Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Injection Capsule Tablets
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Novartis, Pfizer, Merck & Co, AstraZeneca, GSK, Bristol-Myers Squibb, Mylan, Bausch Health, Johnson & Johnson, Bayer, Boehringer Inhelheim, Exelixis, Lunan Pharmaceutical, Sinepharm, CRC, Hai Ni Pharmaceutical, Langtian, NCPC, Hayao, Xinhua Group, Xudong Haipu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Congestive Heart Failure (CHF) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Congestive Heart Failure (CHF) Market report?

Ans: The main players in the Congestive Heart Failure (CHF) Market are Sanofi, Novartis, Pfizer, Merck & Co, AstraZeneca, GSK, Bristol-Myers Squibb, Mylan, Bausch Health, Johnson & Johnson, Bayer, Boehringer Inhelheim, Exelixis, Lunan Pharmaceutical, Sinepharm, CRC, Hai Ni Pharmaceutical, Langtian, NCPC, Hayao, Xinhua Group, Xudong Haipu Pharmaceutical

What are the Application segmentation covered in the Congestive Heart Failure (CHF) Market report?

Ans: The Applications covered in the Congestive Heart Failure (CHF) Market report are Hospital, Clinic

What are the Type segmentation covered in the Congestive Heart Failure (CHF) Market report?

Ans: The Types covered in the Congestive Heart Failure (CHF) Market report are Injection, Capsule, Tablets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injection

1.2.3 Capsule

1.2.4 Tablets

1.3 Market by Application

1.3.1 Global Congestive Heart Failure (CHF) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Congestive Heart Failure (CHF) Market Perspective (2020-2031)

2.2 Global Congestive Heart Failure (CHF) Growth Trends by Region

2.2.1 Global Congestive Heart Failure (CHF) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Congestive Heart Failure (CHF) Historic Market Size by Region (2020-2025)

2.2.3 Congestive Heart Failure (CHF) Forecasted Market Size by Region (2026-2031)

2.3 Congestive Heart Failure (CHF) Market Dynamics

2.3.1 Congestive Heart Failure (CHF) Industry Trends

2.3.2 Congestive Heart Failure (CHF) Market Drivers

2.3.3 Congestive Heart Failure (CHF) Market Challenges

2.3.4 Congestive Heart Failure (CHF) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Congestive Heart Failure (CHF) Players by Revenue

3.1.1 Global Top Congestive Heart Failure (CHF) Players by Revenue (2020-2025)

3.1.2 Global Congestive Heart Failure (CHF) Revenue Market Share by Players (2020-2025)

3.2 Global Congestive Heart Failure (CHF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Congestive Heart Failure (CHF) Revenue

3.4 Global Congestive Heart Failure (CHF) Market Concentration Ratio

3.4.1 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Revenue in 2024

3.5 Global Key Players of Congestive Heart Failure (CHF) Head office and Area Served

3.6 Global Key Players of Congestive Heart Failure (CHF), Product and Application

3.7 Global Key Players of Congestive Heart Failure (CHF), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Congestive Heart Failure (CHF) Breakdown Data by Type

4.1 Global Congestive Heart Failure (CHF) Historic Market Size by Type (2020-2025)

4.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2026-2031)

5 Congestive Heart Failure (CHF) Breakdown Data by Application

5.1 Global Congestive Heart Failure (CHF) Historic Market Size by Application (2020-2025)

5.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Congestive Heart Failure (CHF) Market Size (2020-2031)

6.2 North America Congestive Heart Failure (CHF) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Congestive Heart Failure (CHF) Market Size by Country (2020-2025)

6.4 North America Congestive Heart Failure (CHF) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Congestive Heart Failure (CHF) Market Size (2020-2031)

7.2 Europe Congestive Heart Failure (CHF) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Congestive Heart Failure (CHF) Market Size by Country (2020-2025)

7.4 Europe Congestive Heart Failure (CHF) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size (2020-2031)

8.2 Asia-Pacific Congestive Heart Failure (CHF) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2020-2025)

8.4 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Congestive Heart Failure (CHF) Market Size (2020-2031)

9.2 Latin America Congestive Heart Failure (CHF) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Congestive Heart Failure (CHF) Market Size by Country (2020-2025)

9.4 Latin America Congestive Heart Failure (CHF) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size (2020-2031)

10.2 Middle East & Africa Congestive Heart Failure (CHF) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2020-2025)

10.4 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Congestive Heart Failure (CHF) Introduction

11.1.4 Sanofi Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Congestive Heart Failure (CHF) Introduction

11.2.4 Novartis Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Congestive Heart Failure (CHF) Introduction

11.3.4 Pfizer Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Merck & Co

11.4.1 Merck & Co Company Details

11.4.2 Merck & Co Business Overview

11.4.3 Merck & Co Congestive Heart Failure (CHF) Introduction

11.4.4 Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.4.5 Merck & Co Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Congestive Heart Failure (CHF) Introduction

11.5.4 AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 GSK

11.6.1 GSK Company Details

11.6.2 GSK Business Overview

11.6.3 GSK Congestive Heart Failure (CHF) Introduction

11.6.4 GSK Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.6.5 GSK Recent Development

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Congestive Heart Failure (CHF) Introduction

11.7.4 Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.7.5 Bristol-Myers Squibb Recent Development

11.8 Mylan

11.8.1 Mylan Company Details

11.8.2 Mylan Business Overview

11.8.3 Mylan Congestive Heart Failure (CHF) Introduction

11.8.4 Mylan Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.8.5 Mylan Recent Development

11.9 Bausch Health

11.9.1 Bausch Health Company Details

11.9.2 Bausch Health Business Overview

11.9.3 Bausch Health Congestive Heart Failure (CHF) Introduction

11.9.4 Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.9.5 Bausch Health Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Details

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Congestive Heart Failure (CHF) Introduction

11.10.4 Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.10.5 Johnson & Johnson Recent Development

11.11 Bayer

11.11.1 Bayer Company Details

11.11.2 Bayer Business Overview

11.11.3 Bayer Congestive Heart Failure (CHF) Introduction

11.11.4 Bayer Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.11.5 Bayer Recent Development

11.12 Boehringer Inhelheim

11.12.1 Boehringer Inhelheim Company Details

11.12.2 Boehringer Inhelheim Business Overview

11.12.3 Boehringer Inhelheim Congestive Heart Failure (CHF) Introduction

11.12.4 Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.12.5 Boehringer Inhelheim Recent Development

11.13 Exelixis

11.13.1 Exelixis Company Details

11.13.2 Exelixis Business Overview

11.13.3 Exelixis Congestive Heart Failure (CHF) Introduction

11.13.4 Exelixis Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.13.5 Exelixis Recent Development

11.14 Lunan Pharmaceutical

11.14.1 Lunan Pharmaceutical Company Details

11.14.2 Lunan Pharmaceutical Business Overview

11.14.3 Lunan Pharmaceutical Congestive Heart Failure (CHF) Introduction

11.14.4 Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.14.5 Lunan Pharmaceutical Recent Development

11.15 Sinepharm

11.15.1 Sinepharm Company Details

11.15.2 Sinepharm Business Overview

11.15.3 Sinepharm Congestive Heart Failure (CHF) Introduction

11.15.4 Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.15.5 Sinepharm Recent Development

11.16 CRC

11.16.1 CRC Company Details

11.16.2 CRC Business Overview

11.16.3 CRC Congestive Heart Failure (CHF) Introduction

11.16.4 CRC Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.16.5 CRC Recent Development

11.17 Hai Ni Pharmaceutical

11.17.1 Hai Ni Pharmaceutical Company Details

11.17.2 Hai Ni Pharmaceutical Business Overview

11.17.3 Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Introduction

11.17.4 Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.17.5 Hai Ni Pharmaceutical Recent Development

11.18 Langtian

11.18.1 Langtian Company Details

11.18.2 Langtian Business Overview

11.18.3 Langtian Congestive Heart Failure (CHF) Introduction

11.18.4 Langtian Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.18.5 Langtian Recent Development

11.19 NCPC

11.19.1 NCPC Company Details

11.19.2 NCPC Business Overview

11.19.3 NCPC Congestive Heart Failure (CHF) Introduction

11.19.4 NCPC Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.19.5 NCPC Recent Development

11.20 Hayao

11.20.1 Hayao Company Details

11.20.2 Hayao Business Overview

11.20.3 Hayao Congestive Heart Failure (CHF) Introduction

11.20.4 Hayao Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.20.5 Hayao Recent Development

11.21 Xinhua Group

11.21.1 Xinhua Group Company Details

11.21.2 Xinhua Group Business Overview

11.21.3 Xinhua Group Congestive Heart Failure (CHF) Introduction

11.21.4 Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.21.5 Xinhua Group Recent Development

11.22 Xudong Haipu Pharmaceutical

11.22.1 Xudong Haipu Pharmaceutical Company Details

11.22.2 Xudong Haipu Pharmaceutical Business Overview

11.22.3 Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Introduction

11.22.4 Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025)

11.22.5 Xudong Haipu Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Novartis

Pfizer Inc

Merck

Astrazeneca plc

GSK

Bristol–Myers Squibb

Mylan NV

Bausch Health

Johnson & Johnson

Bayer

Boehringer Inhelheim

Exelixis Inc

Lunan Pharmaceutical

Sinepharm

CRC

Hai Ni Pharmaceutical

Langtian

NCPC

Hayao

Xinhua Group

Xudong Haipu Pharmaceutical

List of Tables

Table 1. Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injection

Table 3. Key Players of Capsule

Table 4. Key Players of Tablets

Table 5. Global Congestive Heart Failure (CHF) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Congestive Heart Failure (CHF) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Congestive Heart Failure (CHF) Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Congestive Heart Failure (CHF) Market Share by Region (2020-2025)

Table 9. Global Congestive Heart Failure (CHF) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Congestive Heart Failure (CHF) Market Share by Region (2026-2031)

Table 11. Congestive Heart Failure (CHF) Market Trends

Table 12. Congestive Heart Failure (CHF) Market Drivers

Table 13. Congestive Heart Failure (CHF) Market Challenges

Table 14. Congestive Heart Failure (CHF) Market Restraints

Table 15. Global Congestive Heart Failure (CHF) Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Congestive Heart Failure (CHF) Market Share by Players (2020-2025)

Table 17. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) as of 2024)

Table 18. Ranking of Global Top Congestive Heart Failure (CHF) Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Congestive Heart Failure (CHF) Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Congestive Heart Failure (CHF), Headquarters and Area Served

Table 21. Global Key Players of Congestive Heart Failure (CHF), Product and Application

Table 22. Global Key Players of Congestive Heart Failure (CHF), Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Congestive Heart Failure (CHF) Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2020-2025)

Table 26. Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2026-2031)

Table 28. Global Congestive Heart Failure (CHF) Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2020-2025)

Table 30. Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2026-2031)

Table 32. North America Congestive Heart Failure (CHF) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Congestive Heart Failure (CHF) Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Congestive Heart Failure (CHF) Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Congestive Heart Failure (CHF) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Congestive Heart Failure (CHF) Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Congestive Heart Failure (CHF) Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Congestive Heart Failure (CHF) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Congestive Heart Failure (CHF) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Congestive Heart Failure (CHF) Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Congestive Heart Failure (CHF) Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Congestive Heart Failure (CHF) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Congestive Heart Failure (CHF) Product

Table 50. Sanofi Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. Novartis Company Details

Table 53. Novartis Business Overview

Table 54. Novartis Congestive Heart Failure (CHF) Product

Table 55. Novartis Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 56. Novartis Recent Development

Table 57. Pfizer Company Details

Table 58. Pfizer Business Overview

Table 59. Pfizer Congestive Heart Failure (CHF) Product

Table 60. Pfizer Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 61. Pfizer Recent Development

Table 62. Merck & Co Company Details

Table 63. Merck & Co Business Overview

Table 64. Merck & Co Congestive Heart Failure (CHF) Product

Table 65. Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 66. Merck & Co Recent Development

Table 67. AstraZeneca Company Details

Table 68. AstraZeneca Business Overview

Table 69. AstraZeneca Congestive Heart Failure (CHF) Product

Table 70. AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 71. AstraZeneca Recent Development

Table 72. GSK Company Details

Table 73. GSK Business Overview

Table 74. GSK Congestive Heart Failure (CHF) Product

Table 75. GSK Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 76. GSK Recent Development

Table 77. Bristol-Myers Squibb Company Details

Table 78. Bristol-Myers Squibb Business Overview

Table 79. Bristol-Myers Squibb Congestive Heart Failure (CHF) Product

Table 80. Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 81. Bristol-Myers Squibb Recent Development

Table 82. Mylan Company Details

Table 83. Mylan Business Overview

Table 84. Mylan Congestive Heart Failure (CHF) Product

Table 85. Mylan Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 86. Mylan Recent Development

Table 87. Bausch Health Company Details

Table 88. Bausch Health Business Overview

Table 89. Bausch Health Congestive Heart Failure (CHF) Product

Table 90. Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 91. Bausch Health Recent Development

Table 92. Johnson & Johnson Company Details

Table 93. Johnson & Johnson Business Overview

Table 94. Johnson & Johnson Congestive Heart Failure (CHF) Product

Table 95. Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 96. Johnson & Johnson Recent Development

Table 97. Bayer Company Details

Table 98. Bayer Business Overview

Table 99. Bayer Congestive Heart Failure (CHF) Product

Table 100. Bayer Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 101. Bayer Recent Development

Table 102. Boehringer Inhelheim Company Details

Table 103. Boehringer Inhelheim Business Overview

Table 104. Boehringer Inhelheim Congestive Heart Failure (CHF) Product

Table 105. Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 106. Boehringer Inhelheim Recent Development

Table 107. Exelixis Company Details

Table 108. Exelixis Business Overview

Table 109. Exelixis Congestive Heart Failure (CHF) Product

Table 110. Exelixis Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 111. Exelixis Recent Development

Table 112. Lunan Pharmaceutical Company Details

Table 113. Lunan Pharmaceutical Business Overview

Table 114. Lunan Pharmaceutical Congestive Heart Failure (CHF) Product

Table 115. Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 116. Lunan Pharmaceutical Recent Development

Table 117. Sinepharm Company Details

Table 118. Sinepharm Business Overview

Table 119. Sinepharm Congestive Heart Failure (CHF) Product

Table 120. Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 121. Sinepharm Recent Development

Table 122. CRC Company Details

Table 123. CRC Business Overview

Table 124. CRC Congestive Heart Failure (CHF) Product

Table 125. CRC Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 126. CRC Recent Development

Table 127. Hai Ni Pharmaceutical Company Details

Table 128. Hai Ni Pharmaceutical Business Overview

Table 129. Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Product

Table 130. Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 131. Hai Ni Pharmaceutical Recent Development

Table 132. Langtian Company Details

Table 133. Langtian Business Overview

Table 134. Langtian Congestive Heart Failure (CHF) Product

Table 135. Langtian Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 136. Langtian Recent Development

Table 137. NCPC Company Details

Table 138. NCPC Business Overview

Table 139. NCPC Congestive Heart Failure (CHF) Product

Table 140. NCPC Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 141. NCPC Recent Development

Table 142. Hayao Company Details

Table 143. Hayao Business Overview

Table 144. Hayao Congestive Heart Failure (CHF) Product

Table 145. Hayao Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 146. Hayao Recent Development

Table 147. Xinhua Group Company Details

Table 148. Xinhua Group Business Overview

Table 149. Xinhua Group Congestive Heart Failure (CHF) Product

Table 150. Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 151. Xinhua Group Recent Development

Table 152. Xudong Haipu Pharmaceutical Company Details

Table 153. Xudong Haipu Pharmaceutical Business Overview

Table 154. Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Product

Table 155. Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2020-2025) & (US$ Million)

Table 156. Xudong Haipu Pharmaceutical Recent Development

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

Table 160. Authors List of This Report

List of Figures

Figure 1. Congestive Heart Failure (CHF) Picture

Figure 2. Global Congestive Heart Failure (CHF) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Congestive Heart Failure (CHF) Market Share by Type: 2024 VS 2031

Figure 4. Injection Features

Figure 5. Capsule Features

Figure 6. Tablets Features

Figure 7. Global Congestive Heart Failure (CHF) Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Congestive Heart Failure (CHF) Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Congestive Heart Failure (CHF) Report Years Considered

Figure 12. Global Congestive Heart Failure (CHF) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Congestive Heart Failure (CHF) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Congestive Heart Failure (CHF) Market Share by Region: 2024 VS 2031

Figure 15. Global Congestive Heart Failure (CHF) Market Share by Players in 2024

Figure 16. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Revenue in 2024

Figure 18. North America Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Congestive Heart Failure (CHF) Market Share by Country (2020-2031)

Figure 20. United States Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Congestive Heart Failure (CHF) Market Share by Country (2020-2031)

Figure 24. Germany Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Region (2020-2031)

Figure 32. China Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Congestive Heart Failure (CHF) Market Share by Country (2020-2031)

Figure 40. Mexico Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Country (2020-2031)

Figure 44. Turkey Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Congestive Heart Failure (CHF) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sanofi Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 50. Merck & Co Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 52. GSK Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 54. Mylan Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 55. Bausch Health Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 56. Johnson & Johnson Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 58. Boehringer Inhelheim Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 59. Exelixis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 60. Lunan Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 61. Sinepharm Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 62. CRC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 63. Hai Ni Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 64. Langtian Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 65. NCPC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 66. Hayao Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 67. Xinhua Group Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 68. Xudong Haipu Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions